-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: United States Patent and Trademark Office
PTO Director Kappos Remarks at Innovation Alliance Conference: IP leads to job growth
Thank you Roger [Martin], for that kind introduction. I would like to thank the Innovation Alliance for having me in today to speak with you about intellectual property’s vital role in today’s innovation economy. America stands at a critical juncture in our economic evolution, and intellectual property will play a key role in driving our economic growth and renewal. As technological advances bring great change to the speed and complexity of American innovation, strong intellectual Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor
BIO’s IP Priorities for 2011
As we start a new year, the BIO Intellectual Property Department has determined their 2011 priorities. Intellectual Property remains a foundational priority for BIO and our 1100 biotechnology company members. BIO’s IP department has approved the following priorities for 2011: 1) PTO reforms to improve efficient, timely and quality examination 2) Congressional patent reform legislation 3) Improving IP protection in key foreign markets 4) IP legal developments in the courts 5) Protecting the breadth and flexibility of the patent Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Bayh-Dole, BIO, Biotechnology Industry Organization, economic development, Intellectual Property, International, IP, Patent Reform, patent reform in foreign markets, patents, Supreme Court, Technology Transfer, Technology Transfer, United States Patent and Trademark Office
Tags: Bayh-Dole, BIO, Biotechnology Industry Organization, economic development, Intellectual Property, International, IP, Patent Reform, patent reform in foreign markets, patents, Supreme Court, Technology Transfer, Technology Transfer, United States Patent and Trademark Office
Innovation Alliance Event “Patents, Innovation and Job Creation: A Virtuous Circle”
An event is coming up on patents, innovation and job creation at the Newseum on Friday January 21. The keynote speakers are PTO Director David Kappos and Retired Chief Judge of the Federal Circuit Paul Michel. Other industry experts and executives will participate in panel discussions. Below is the news release. As the U.S. economy struggles with high unemployment, the Innovation Alliance hosts a half-day discussion with inventors, entrepreneurs, business leaders, and industry experts on the Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: David Kappos, economic development, economic growth, Events, Gene Quinn, Gregory Junemann, Hank Nothhaft, Harry Leonhardt, innovation, Innovation Alliance, job creation, Kim Hart, Lisa Kuuttila, patent, patents, Paul Michel, Robert Alt, United States Patent and Trademark Office, US Federal Circuit of Appeals, William Merritt
Tags: David Kappos, economic development, economic growth, Events, Gene Quinn, Gregory Junemann, Hank Nothhaft, Harry Leonhardt, innovation, Innovation Alliance, job creation, Kim Hart, Lisa Kuuttila, patent, patents, Paul Michel, Robert Alt, United States Patent and Trademark Office, US Federal Circuit of Appeals, William Merritt
USPTO Economic Research Agenda
The USPTO has a new Office of the Chief Economist and they have recently published their research agenda. USPTO Economic Research Agenda The OCE is embarking upon an aggressive economic research program to provide evidence on a range of matters relevant to policymaking and the effect of IP on economic outcomes more generally. These include: (1) Relating IP to economic growth, performance and employment, including: (a) IP and entrepreneurship (b) IP and wider Read More >
Is the Myriad Case Decision and/or the DOJ Brief TRIPS Compliant?
Judge Sweet seemed to dismiss Myriad’s constitutional taking and TRIPS claims by indicating: “Finally, Myriad’s suggestion that invalidating the patents-in-suit would constitute an unconstitutional taking in violation of the Fifth Amendment of the Constitution or a violation of the United States’ obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (“TRIPS”) is unpersuasive. Myriad’s novel taking argument runs counter to a long history of invalidation of patent claims by the courts and is unsupported by legal Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: BIO, Department of Justice, DNA, DNA patents, DOJ, gene, Gene Patents, gene patents, Global Health, International, International law, isolated and purified DNA, isolated DNA, Judge Sweet, Myriad, Patent Reform, patents, TRIPS, United States Patent and Trademark Office
Tags: BIO, Department of Justice, DNA, DNA patents, DOJ, gene, Gene Patents, gene patents, Global Health, International, International law, isolated and purified DNA, isolated DNA, Judge Sweet, Myriad, Patent Reform, patents, TRIPS, United States Patent and Trademark Office
